Growth Factors

  • Nancy E. Kline
Part of the Pediatric Oncology book series (PEDIATRICO, volume 22)


Natural Killer Hematopoietic Growth Factor Mobilize Stem Cell Platelet Recovery Myeloid Growth Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Holmes, F. A., O’Shaughnessy, J. A., Vukelja, S., Jones, S. E., Shogan, J., Savin, M., Glaspy, J., Moore, M., Meza, L., Wiznitzer, I., Neumann, T. A., Hill, L. R., Liang, B. C. (2002) Blinded, randomized, multicenter study to evaluate single administration peg.lgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage I or stage III/VI breast cancer. Journal of Clinical Oncology, 20:727–731PubMedGoogle Scholar
  2. Levine, J.E., Boxer, L.A. (2002) Clinical applications of hematopoietic growth factors in pediatric oncology. Current Opinions in Hematology, 9:222–227Google Scholar
  3. Maslak, P., Nimer, S.D. (1998). The efficacy of IL-3, SCF, IL-6 and IL-11 in treating thrombocytopenia. Seminars in Hematology, 35:253–260PubMedGoogle Scholar
  4. Reynolds, C.H. (2000). Clinical efficacy of rhIL-11. Oncology 14(9 Suppl 8):32–40Google Scholar
  5. Wolff, S.N., Herzig, R., Lynch, J., Ericson, S.G., Greer, J.P., Stein, R., Goodman, S., Benyunes, M.C., Ashby, M., Jones, D.V., Fay, J. (2001) Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: A phase I pharmacokinetic and pharmacodynamic study. Bone Marrow Transplantation 27:261–268PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Nancy E. Kline

There are no affiliations available

Personalised recommendations